I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 5 studies | 27% ± 9% | |
| oligodendrocyte | 5 studies | 22% ± 5% | |
| endothelial cell | 3 studies | 21% ± 3% | |
| epithelial cell | 3 studies | 27% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 5 studies | 27% ± 9% | |
| oligodendrocyte | 5 studies | 22% ± 5% | |
| endothelial cell | 3 studies | 21% ± 3% | |
| epithelial cell | 3 studies | 27% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 25% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1927.58 | 1444 / 1445 | 100% | 10.90 | 183 / 183 |
| breast | 100% | 2734.17 | 459 / 459 | 100% | 14.82 | 1116 / 1118 |
| brain | 100% | 2008.22 | 2641 / 2642 | 100% | 22.38 | 704 / 705 |
| prostate | 100% | 2784.68 | 245 / 245 | 100% | 10.82 | 501 / 502 |
| lung | 100% | 2583.57 | 578 / 578 | 100% | 9.39 | 1151 / 1155 |
| intestine | 100% | 2089.60 | 966 / 966 | 100% | 8.91 | 525 / 527 |
| bladder | 100% | 2036.76 | 21 / 21 | 99% | 9.14 | 500 / 504 |
| thymus | 100% | 2731.09 | 653 / 653 | 99% | 9.76 | 598 / 605 |
| adrenal gland | 100% | 1737.10 | 258 / 258 | 99% | 7.88 | 227 / 230 |
| pancreas | 100% | 1367.40 | 327 / 328 | 99% | 8.93 | 176 / 178 |
| kidney | 100% | 2049.80 | 89 / 89 | 99% | 10.06 | 888 / 901 |
| ovary | 100% | 2170.23 | 180 / 180 | 98% | 7.05 | 422 / 430 |
| stomach | 100% | 1642.62 | 359 / 359 | 98% | 9.42 | 280 / 286 |
| uterus | 100% | 2588.32 | 170 / 170 | 98% | 8.43 | 448 / 459 |
| skin | 100% | 2427.41 | 1809 / 1809 | 97% | 12.73 | 460 / 472 |
| liver | 100% | 1122.88 | 226 / 226 | 85% | 4.86 | 346 / 406 |
| adipose | 100% | 2524.61 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1903.36 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2209.75 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 8.60 | 1 / 1 |
| heart | 99% | 1118.43 | 853 / 861 | 0% | 0 | 0 / 0 |
| muscle | 96% | 729.83 | 773 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 7.54 | 43 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 6.16 | 27 / 29 |
| eye | 0% | 0 | 0 / 0 | 76% | 5.25 | 61 / 80 |
| peripheral blood | 42% | 709.06 | 394 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005634 | Cellular component | nucleus |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ZNF621 |
| Protein name | Zinc finger protein 621 |
| Synonyms | |
| Description | FUNCTION: May be involved in transcriptional regulation. |
| Accessions | ENST00000453351.1 C9JZC2 Q6ZSS3 ENST00000339296.10 [Q6ZSS3-1] ENST00000310898.5 [Q6ZSS3-2] ENST00000431278.5 C9JM43 ENST00000403205.6 [Q6ZSS3-1] |
